IBJNews

Lilly collaboration with outside researchers yields first deal

Back to TopCommentsE-mailPrintBookmark and Share

Indianapolis-based Eli Lilly and Co. has struck its first deal under an open-collaboration program launched last year to evaluate the potential of compounds synthesized in university and biotech labs.

After receiving data on more than 30,000 compounds from researchers in 26 countries, the first collaborative agreement was reached in its own back yard, with University of Notre Dame researchers Marvin Miller and Garrett Moraski.

They‘ll work with Lilly scientists for at least the next year to discover the potential of the Notre Dame compounds to starve the blood flow to tumors.

While there’s nothing new about collaborations with outside researchers, Lilly’s Phenotypic Drug Discovery Initiative, or PD2, is to provide a more convenient entry point for outside researchers into Lilly’s drug-discovery and -development process.

It allows the drugmaker to establish relationships with outside scientists that may not have worked with Lilly before. The ultimate goal is finding a promising compound, which an outside researcher might otherwise leave on the shelf, and turn it into the next blockbuster drug.

PD2 consists of a secure Web portal that researchers use to submit the structure of their compounds for an initial computational analysis by Lilly. If it shows promise, a researcher is invited to submit a biological sample for testing.

The outside researchers receive more extensive data on the compound’s biological profile than what generally is possible in academic or government labs, Lilly says.

In return, Lilly gets first rights to exclusively negotiate a collaboration or licensing agreement.

“This is the first of many” collaborations to be formalized in the months ahead, said Alan Palkowitz, vice president of discovery chemistry research and technologies at Lilly.

Lilly has about 70 of its own compounds in the pipeline at its labs worldwide. As research and development costs have risen, Lilly and its competitors have been forging alliances with outside companies—licensing their technologies or outright buying the firms.

The PD2 program’s approach is believed to be unique among big drug companies. About two-thirds of interest in PD2 so far has come from university researchers.

Traditionally, a pharmaceutical company might buy technology from a university lab and the relationship might end then and there, Notre Dame’s Miller said.

He says Lilly’s approach goes beyond a financial transaction in that his team has received valuable data from Lilly – 90-some pages from the analysis of Notre Dame’s compound that originally was synthesized to treat tuberculosis.

“The intricacy of the data was really rich from a researcher’s point of view,” said Miller’s colleague, Moraski.

Such data can be used as part of further research and can improve the odds of a researcher's landing a federal grant, as well.

“Our upfront transaction currency is not money. It’s actually data,” said Lilly’s Palkowitz.

The Notre Dame researchers will work directly with Lilly scientists for the at least the next year, something Moraski, who is passionate about finding ways to combat cancer, finds rewarding as well.

Such collaborations help Lilly leverage the expensive investment it has made over the years in its assay system to evaluate compounds to treat Alzheimer’s disease, cancer, diabetes and osteoporosis.

One of Lilly’s best-known products, the cancer drug Alimta, stemmed from a collaboration with Princeton University researcher Edward C. Taylor. The drug rang up sales of more than $2 billion last year.

 

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. Angela IS the best RD

  2. We are a nation of speed. All of our younger lives are filled with deadlines, quotas and bottom lines. We start to ease out of the pressured rat-race when we finally see "retirement." The most enjoyable travel on the planet is passenger rail service. Indy to Chicago does not beat Megabus or Southwest Airlines in speed. Passenger rail however has the best seating, mammoth legroon, seat backs that recline to more than 45 degrees and employers that really want you to return as a customer. Indiana municipalities need to maintain subsidies to support this transportation mode. Losing it is loss for all of us.

  3. Good day! I just want to testify how i got my loan from Mr. Eric Lefkofsky after i applied several times from various loan lenders who claimed to also testify right in this forum,i thought the testimonies where real and i applied but they never gave me loan. I was in need of an urgent loan to start a business and i applied from various loan lenders who promised to help but they never gave me the loan. Until a friend of mine introduce me to this popular Mr. Eric Lefkofsky who promised to help me and indeed he did as he promised without any form of delay. I never thought there are still reliable loan lenders until i met Mr. Eric lefkofsky who indeed helped me with the loan and changed my belief. I promised to share this testimony after I got my loan. I don't know if you are in any way in need of a genuine and urgent loan,free feel to contact Mr. Eric Lefkofsky via their email{grouponfunding@hotmail.com}

  4. Its a THUG issue. Bleecker Street and NYX are thug bars. They attract thugs of all races. Places that attract thugs need to be kicked out of Broad Ripple. Ain't nobody got time for that!

  5. Hello everyone, My name is Marian Gareth, I am from the Texas, United State, am here to testify of how i got my loan from Mr Andre Frank {frankloancompany@yahoo.com} after i applied Two times from various loan lenders who claimed to be lenders right in this forum,i thought their lending where real and i applied but they never gave me loan. I was in need of an urgent loan to start a business and i applied from various loan lenders who promised to help but they never gave me the loan.Until a friend of mine introduce me to Mr Andre Frank the C.E.O of Andre Frank Loan Company who promised to help me with a loan of my desire and he really did as he promised without any form of delay, I never thought there are still reliable loan lenders until i met Mr Andre Frank, who really help me with my loan and changed my lief for better. I don't know if you are in need of an urgent loan, free feel to contact Mr Andre Frank on his email{ Frankloancompany@yahoo.com} for help

ADVERTISEMENT